Sanara MedTech (SMTI) Cost of Revenue (2010 - 2026)

Sanara MedTech has reported Cost of Revenue for 16 years, with the latest figure at $1.9 million in Q1 2026.

• For the quarter ending Q1 2026, Cost of Revenue rose 4.83% year-over-year to $1.9 million; the trailing twelve-month figure through Mar 2026 stood at $7.6 million (down 5.88% YoY), and the FY2025 full-year result was $7.5 million, down 7.6% from the prior year.
• Cost of Revenue for Q1 2026 stood at $1.9 million, up from $1.9 million in the prior quarter.
• The five-year high for Cost of Revenue was $2.4 million in Q4 2022, with the low at $805081.0 in Q1 2022.
• Historically, Cost of Revenue has averaged $1.9 million across 5 years, with a median of $1.9 million in 2026.
• Annual changes were most pronounced in 2022 — Cost of Revenue soared 330.55% — and 2023, when it declined 24.52%.
• Sanara MedTech's Cost of Revenue stood at $2.4 million in 2022, then decreased by 24.52% to $1.8 million in 2023, then gained by 25.78% to $2.2 million in 2024, then slipped by 16.66% to $1.9 million in 2025, then rose by 2.62% to $1.9 million in 2026.
• The last three Cost of Revenue figures came in at $1.9 million (Q1 2026), $1.9 million (Q4 2025), and $1.9 million (Q3 2025), per Business Quant data.